“Safra Taşı Hastalığının Serum RBP4 Düzeyi, D Vitamini, Lipid Profili, İnsülin Direnci ve Ürik Asit Düzeyleri ile İlişkisi” üzerine yorum

Yıl 2025, Cilt: 7 Sayı: 1, 148 - 150, 25.02.2025

Betül Doğantekin , Başak Çakır Güney

https://doi.org/10.52827/hititmedj.1520691

Öz

We read with great interest the research article titled “The Relationship of Gallstone Disease with
Serum RBP4 Level, Vitamin D, Lipid Profile, Insulin Resistance and Uric Acid Levels” by Kurt İnci et al.,
published in the second issue of Hitit Journal of Science in 2024 (1). We would like to express our
gratitude to the authors and the editorial team for their valuable contributions. Through this letter,
we aim to highlight specific elements that we believe will enrich the ongoing discussion around the
article.

Anahtar Kelimeler

Serum RBP4 Düzeyi, D Vitamini, Lipid Profili, İnsülin Direnci, Ürik Asit

Comment on “The Relationship of Gallstone Disease with Serum RBP4 Level, Vitamin D, Lipid Profile, Insulin Resistance and Uric Acid Levels”

Öz

We read with great interest the research article titled “The Relationship of Gallstone Disease with Serum RBP4 Level, Vitamin D, Lipid Profile, Insulin Resistance and Uric Acid Levels” by Kurt İnci et al., published in the second issue of Hitit Journal of Science in 2024 (1). We would like to express our gratitude to the authors and the editorial team for their valuable contributions. Through this letter, we aim to highlight specific elements that we believe will enrich the ongoing discussion around the article.

Anahtar Kelimeler

Serum RBP4 Level, Vitamin D, Lipid Profile, Insulin Resistance, Uric Acid

Kaynakça

• Kurt İnci B, İnci K, Paşaoğlu Ö, Pasaoglu H, Dumlu GŞ. The Relationship of Gallestone Disease with Serum RBP4 Level, Vitamın D, Lipid Profile, Insulin Resistance and UricAcid Levels. Hitit Medical Journal. June 2024;6(2):161-169.
• Zhang J, Chen L, Shen K, et al. Association between metabolically healthy overweight/obesity and gallstones in Chinese adults. Nutr Metab 2023;20(1):20. https://doi. org/10.1186/s12986-023-00741-4.
• Jennifer A. Hirst, Andrew J. Farmer, Raghib Ali, Nia W. Roberts, Richard J. Stevens; Quantifying the Effect of Metformin Treatment and Dose on Glycemic Control. Diabetes Care 2012;35(2):446–454.
• Gustafsson D, Unwin R. The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC Nephrol. 2013;14:164.
• Cao, A.M., Eslick, G.D. (2018). Epidemiology and Pathogenesis of Gallstones. In: Cox, M., Eslick, G., Padbury, R. (eds) The Management of Gallstone Disease. Springer, Cham.